--:--:--LOCAL ·--:--UTC
    US EQUITIESLAST CLOSE
    AAPL$349.21-0.92%
    MSFT$498.30-1.97%
    GOOGL$272.66-3.46%
    AMZN$257.37-3.87%
    NVDA$145.98-3.30%
    META$596.22-3.27%
    TSLA$374.41-2.43%
    NFLX$58.46-2.27%
    BRK.B$572.04-0.45%
    AVGO$346.65-2.09%
    DIS$120.25-1.72%
    SBUX$104.47-4.25%
    MCD$272.35-0.61%
    NKE$34.33-5.45%
    COST$1093.83-0.25%
    WMT$126.04-1.04%
    HD$336.68-0.28%
    KO$96.09-2.04%
    PG$167.85-1.43%
    ORCL$110.57-2.92%
    CRM$183.31-3.72%
    ADBE$221.68-2.00%
    AMD$489.19-7.72%
    INTC$55.72+1.92%
    QCOM$162.01+1.38%
    CSCO$94.70-2.55%
    IBM$223.88-2.03%
    UBER$65.60-4.60%
    ABNB$172.79-4.12%
    SHOP$131.97-5.34%
    PYPL$56.37-2.63%
    COIN$108.87-1.48%
    PLTR$153.68-1.91%
    HOOD$68.65-0.75%
    JPM$320.22-1.20%
    V$402.25-3.12%
    MA$626.50-2.62%
    BAC$48.57-0.70%
    GS$847.53-2.94%
    LLY$1351.12-2.29%
    UNH$330.48-5.55%
    JNJ$267.14-2.04%
    PFE$27.54-1.85%
    XOM$158.93-1.03%
    BA$160.51-1.47%
    BABA$83.31-1.26%
    TSM$352.09-2.90%
    US EQUITIESLAST CLOSE
    AAPL$349.21-0.92%
    MSFT$498.30-1.97%
    GOOGL$272.66-3.46%
    AMZN$257.37-3.87%
    NVDA$145.98-3.30%
    META$596.22-3.27%
    TSLA$374.41-2.43%
    NFLX$58.46-2.27%
    BRK.B$572.04-0.45%
    AVGO$346.65-2.09%
    DIS$120.25-1.72%
    SBUX$104.47-4.25%
    MCD$272.35-0.61%
    NKE$34.33-5.45%
    COST$1093.83-0.25%
    WMT$126.04-1.04%
    HD$336.68-0.28%
    KO$96.09-2.04%
    PG$167.85-1.43%
    ORCL$110.57-2.92%
    CRM$183.31-3.72%
    ADBE$221.68-2.00%
    AMD$489.19-7.72%
    INTC$55.72+1.92%
    QCOM$162.01+1.38%
    CSCO$94.70-2.55%
    IBM$223.88-2.03%
    UBER$65.60-4.60%
    ABNB$172.79-4.12%
    SHOP$131.97-5.34%
    PYPL$56.37-2.63%
    COIN$108.87-1.48%
    PLTR$153.68-1.91%
    HOOD$68.65-0.75%
    JPM$320.22-1.20%
    V$402.25-3.12%
    MA$626.50-2.62%
    BAC$48.57-0.70%
    GS$847.53-2.94%
    LLY$1351.12-2.29%
    UNH$330.48-5.55%
    JNJ$267.14-2.04%
    PFE$27.54-1.85%
    XOM$158.93-1.03%
    BA$160.51-1.47%
    BABA$83.31-1.26%
    TSM$352.09-2.90%
    Plug stock market data into your AI agent — one command: Get your free API key →
    LoginGet API Key
    Company data coverage · NYSE

    DGX — Quest Diagnostics

    Data coverage, completeness and provenance for Quest Diagnostics in the Stock Market API — Health Care · Diagnostics & Research.

    NYSE USA S&P 500
    Core-field completeness
    94.1%
    Statement periods
    FY2021–FY2025
    Filings archived
    0
    Price collection time
    2026-11-19 22:36 UTC

    Stored price coverage

    Source date: 2026-11-19T21:02:40. Source: yfinance. Collection time is shown separately and does not establish a trade date.

    Recent stored price bars, without investment interpretation
    DateCloseCurrencySourceAdjustment basis
    2026-11-19259.0900USDyfinanceSplit- and dividend-adjusted close
    2026-11-18259.6900USDyfinanceSplit- and dividend-adjusted close
    2026-11-17256.3500USDyfinanceSplit- and dividend-adjusted close
    2026-11-16262.2100USDyfinanceSplit- and dividend-adjusted close
    2026-11-13259.6000USDyfinanceSplit- and dividend-adjusted close

    GET /api/v1/companies/DGX/prices · Price parameters and adjustment semantics

    No archived filings are currently stored for this listing.

    Dataset availability · Handle missing data

    Profile

    Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

    Employees: 60,000 · Website: https://www.questdiagnostics.com · Profile fields populated: 75%

    Data completeness by statement

    Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/DGX/financials.

    Income statement8/10 fields (80.0%)
    Balance sheet11/14 fields (78.6%)
    Cash flow6/6 fields (100.0%)
    Per-share3/4 fields (75.0%)

    Financial statement coverage (USD)

    Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

    PeriodPeriod end RevenueNet incomeTotal assetsTotal equity Fields populatedSource
    FY2025 (USD) 2025-12-31 28 sec_edgar
    FY2024 (USD) 2024-12-31 28 sec_edgar
    FY2023 (USD) 2023-12-31 29 sec_edgar
    FY2022 (USD) 2022-12-31 29 sec_edgar
    FY2021 (USD) 2021-12-31 29 sec_edgar

    Get DGX data via the API

    The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.

    Company profile

    Name, sector, industry, HQ, employees, market cap, source-tagged.

    GET /api/v1/companies/DGX

    Financial statements

    Multi-year statements with per-field source tags and completeness.

    GET /api/v1/companies/DGX/financials

    Computed ratios

    P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

    GET /api/v1/companies/DGX/metrics/summary

    News & announcements

    Dated press releases and announcements with source links.

    GET /api/v1/companies/DGX/news

    Quick start

    Create a free key, then:

    curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/DGX

    Query DGX programmatically

    Free tier — instant API key. Built for AI agents.

    Frequently Asked Questions

    What data does the API provide for DGX?
    Stored coverage for DGX: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/DGX; inspect available source metadata for provenance.
    How complete is DGX's financial data?
    The anchor reporting period (FY2025) has 94.1% of the 17 core statement fields populated. Primary source: sec_edgar.
    What reporting periods are covered for DGX?
    5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/DGX/financials.
    Where does DGX's data come from?
    Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/DGX/financials; missing tags do not establish provenance.